Agile


Agile Initiated With A Buy At Janney Capital; Considers AGRX A Compelling Investment

Janney Capital analyst Kimberly Lee is out today with an interesting call initiating Agile Therapeutics, Inc. (AGRX) with a Buy rating and $18¬†fair …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts